IOVA Iovance Biotherapeutics, Inc.
$14.58▲ +5.81%
Healthcare
Other
After hours
$14.55▼ -0.21%
Oct 27, 6:00 PM ET
Volume 8.78M
Avg Volume (10D) 10.14M
Key Metrics & Fundamentals
Market Cap
$6.60B
P/E Ratio
–
Div Yield
0.00%
52W Range
1.76 - 15.37
% vs 50 MA
30.24%
% vs 200 MA
155.43%
RSI-14
61.6
MACD Histogram
-0.2100
Beta (1Y vs SPY)
1.22
Free Cash Flow
-$66.28M
Gross Rev
$99.31M
Gross Profit
$55.72M
EBITDA
-$41.50M
COGS
$43.60M
Operating Exp
$107.62M
Operating Income
-$51.91M
EBIT
-$51.91M
Pretax Income
-$48.69M
Net Income
-$47.32M
EPS (Diluted)
-0.11
Price & Volume History
Loading chart…
Recent News
Best Momentum Stocks to Buy for October 27th
Zacks · Oct 27, 2026 9:00 AM ET
Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year?
Zacks · Oct 27, 2026 8:40 AM ET
Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026
GlobeNewswire · Oct 27, 2026 7:00 AM ET
New Strong Buy Stocks for October 27th
Zacks · Oct 27, 2026 5:55 AM ET
Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026
GlobeNewswire · Oct 26, 2026 7:00 AM ET
Stocktwits Pharma Pulse: Big Pharma Earnings, Cancer Updates And 2 FDA Deadlines — The Week’s Biotech Watchlist
Stocktwits · Oct 25, 2026 10:28 PM ET
Iovance’s Melanoma Therapy Shows Promising 4-Year Data – Retail Says Acquisition Imminent Before 2027-End
Stocktwits · Oct 23, 2026 1:04 PM ET
Iovance Biotherapeutics Reports 62.5% Overall Response Rate in Phase 2 Melanoma Trial
MT Newswires · Oct 23, 2026 11:14 AM ET
Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma
GlobeNewswire · Oct 23, 2026 10:15 AM ET
Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026
GlobeNewswire · Oct 19, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IOVA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.